Shemille A. Collingwood
Mount Sinai Medical Center, Icahn School of Medicine at Mount Sinai
Papers
6
Total Citations
68
H-Index
4
About
Shemille A. Collingwood is a urologic surgeon and researcher whose work focuses on improving outcomes for men with prostate cancer, with a particular emphasis on health disparities, surgical innovation, and risk stratification. Her most cited study, with 36 citations, revealed that African American men experience significantly higher decisional regret after robotic-assisted laparoscopic prostatectomy, highlighting critical racial disparities in surgical decision-making and postoperative quality of life. Collingwood has also investigated how metabolic syndrome affects surgical outcomes, providing valuable insights for managing prostate cancer in patients with complex comorbidities. Her research on the heterogeneity of D’Amico intermediate-risk prostate cancer patients—examining the influence of primary and secondary Gleason scores—has helped refine risk classification to better predict outcomes after radical prostatectomy. Additionally, she has explored the clinical significance of MRI-undetectable tumors for active surveillance protocols and the modulating effects of benign prostate enlargement medications on Gleason upgrading. Through these contributions, Collingwood has advanced personalized surgical care and deepened the understanding of how patient-specific factors—from race to metabolic health—shape prostate cancer treatment outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2Robotic-assisted laparoscopic prostatectomy in men with metabolic syndrome16 citations · 2013
- 3
- 4
- 5
- 6